Latest news with #MCL
USA Today
a day ago
- Sport
- USA Today
The list of Lions players at OTA with limited or no practice
The list of Lions players at OTA with limited or no practice The Lions held an OTA session open to the media. Here's who is coming off injuries that practiced, those that sat out, and more. Dan Campbell had his first OTA (organized team activities) press conference today and offered player availability information. For the players that are limited or not practicing, Campbell was quick to state: Some of them are so minor. The rookies have been training for the combine.... We're just trying to be smart. We got little dings here. This is the time of year to make sure that we're being more conservative. The following is Campbell's list of players that are at OTA but with limited or no practice. Included are my possible reasons for the player's limited availability. Players that were expected to be limited or out Alim McNeill - ACL Malcolm Rodriguez - ACL Tyleik Williams - hamstring Mekhi Wingo - knee meniscus surgery Derrick Barnes - MCL/PCL surgery Khalil Dorsey - tibia/fibula fracture David Montgomery - MCL Players that were unexpected to be limited or out Amon-Ra St. Brown - No concerns coming out of last season. Brodric Martin - Right knee hyperextension last preseason and missed half the year. Levi Onwuzurike - L5-S1 spinal fusion in 2022 could require ongoing load management. Josh Paschal - Missed 1 game with right knee in week 14. DJ Reader - Missed 1 game with left shoulder in week 14. Jack Campbell - Played all games last season. During OTA, he stated he had a minor hip operation this offseason that shouldn't be a concern going forward. Terrion Arnold - Minor right foot injury in week 18. Brian Branch - Multiple minor right leg issues in second half of last season. Miles Frazier - Healthy coming out of college with no concerns. Kenny Yeboah - Possible core muscle injury in 2024. Myles Adams - Clean medical history. Isaac TeSlaa - Healthy coming out of college with no concerns. Sione Vaki - Missed 1 game with a right knee in week 9 last season. Notable players with "full" participation at OTA Aidan Hutchinson - The lack of a "limited" designation sends the clear signal that he will be ready to start the season following his tibia/fibula fracture 7.5 months ago. Marcus Davenport - Still wearing a left elbow wrap at OTA from his reported triceps rupture 8 months ago, but will be ready for the season. Amik Robertson - His left humerus fracture is fully healed. Ahmed Hassanein - Confirmation that his right ankle injury from college is not an issue. Ennis Rakestraw - Hamstring that caused him to miss that last two months of the season is healed up. Graham Glasgow - Knee issue from last season is hopefully a thing of the past. Pat O'Connor - Calf injury in week 18 is fine now.
NBC Sports
2 days ago
- Sport
- NBC Sports
DeMarvion Overshown is making progress in his rehab but knows it's "a process"
Cowboys linebacker DeMarvion Overshown is trying to come back from the ACL, MCL and PCL he tore in his right knee in Week 14. Despite his recent declaration that he wants to compete for comeback player of the year, Overshown's 2025 season is in jeopardy. 'I know it's a process; it's something we're not rushing just because I look good,' Overshown said, via Tommy Yarrish of the team website. 'There's no need to rush the process. I'm going to come back when I'm 100 percent, when I'm ready, when I know I can tough the field and not have to look down and worry about my knee.' Overshown knows what he's in for, having torn the ACL in his left knee in the preseason before his rookie season in 2023. He is optimistic about where he is. He began light jogging this week, and he said he's shuffling and backpedaling. 'It's going real good,' Overshown said. 'I think it really couldn't be any better. If it was better, I'd probably be out there playing right now. Where I'm at in my rehab, in my process, it's where I'm supposed to be plus some.'
Evening Standard
3 days ago
- Health
- Evening Standard
'It's rough': Kath and Kim star Magda Szubanski shares rare and aggressive cancer diagnosis
According to Cancer Research UK, 600 people are diagnosed with MCL in the UK each year. Of all people with non-Hodgkin lymphoma (NHL) in the UK, approximately 5 in every 100 are diagnosed with mantle cell lymphoma.
Time of India
3 days ago
- Health
- Time of India
What is Nordic protocol, a treatment routine for rare and aggressive cancers?
While cancer always seems to be undefeatable, a special treatment routine is getting more attention. Australian comedian Magda Szubanski recently spoke about a special treatment she will be opting for after being diagnosed with stage four Mantle Cell Lymphoma (MCL), which is a rare and aggressive form of blood cancer. 'It's serious, but I've started one of the best treatments available (the Nordic protocol),' the 64-year-old told the media. Mantle Cell Lymphoma (MCL) is a rare and aggressive type of non-Hodgkin lymphoma that starts in the "mantle zone" of lymph nodes. It often spreads quickly to other parts of the body like the bone marrow, spleen, and gastrointestinal tract. Symptoms can include swollen lymph nodes, fatigue, weight loss, and night sweats. Because it's fast-growing, MCL typically requires immediate and intensive treatment, including chemotherapy, immunotherapy, and sometimes stem cell transplants. While it's challenging to cure, newer targeted therapies, like Nordic protocol, are offering hope and better outcomes for many patients living with MCL. What is Nordic protocol? The Nordic Protocol is a specific type of cancer treatment plan, mostly used for certain blood cancers, especially lymphomas like Burkitt lymphoma and leukemias in kids and young adults. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 40대 이상이고 PC가 있으세요? 그럼 이 게임을 정말 좋아하실 거예요! Sea of Conquest 플레이하기 Undo It's called 'Nordic' because it was originally developed and used in—you guessed it—Nordic countries like Sweden, Denmark, Norway, Finland, and Iceland. Now, this isn't some fancy herbal remedy or treatment. It's hardcore, hospital-based chemotherapy—a very structured, carefully planned combo of cancer-killing drugs designed to wipe out fast-growing cancer cells in the blood and lymph system. So what makes it special? The Nordic Protocol is intense. It uses a mix of powerful chemo drugs, often including things like cyclophosphamide, methotrexate, cytarabine, and doxorubicin (each one does a different job). It's very targeted and time-sensitive. The Nordic Protocol is known for being aggressive but precise, which means it's hard on the cancer but tries to be as manageable as possible for the patient. Because it was created for young patients, doctors try to balance effectiveness with fewer long-term side effects. Does it work? Yup, it's got a pretty good track record—high cure rates for certain lymphomas, especially when caught early. It's widely respected around the world, especially in pediatric oncology circles. That said, it's not a one-size-fits-all plan. Doctors customize it based on things like your age, how advanced the cancer is, and how your body responds to early treatments. One step to a healthier you—join Times Health+ Yoga and feel the change
Daily Mail
3 days ago
- Health
- Daily Mail
What is mantle cell lymphoma?
Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma that causes white blood cells to grow and multiply uncontrollably. The average age at diagnosis is 60 to 65 years and is two to three times more common in men than women. The initial symptom of MCL is usually a painless swelling in the neck, armpit, and/or groin. It is usually treated with combination chemotherapy, but other therapies include radioimmunotherapy, radiotherapy and stem cell transplants. It is aggressive and often comes back after patients go into remission.
